3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
4
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
7
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Penile Neoplasms
1
Pathologic Complete Response
1
Mesothelioma, Malignant
1
Lung Neoplasms
1
Brain Neoplasms
1
Interventions
Docetaxel
17
Surveys and Questionnaires
15
pembrolizumab
14
Specimen Handling
10
Radiotherapy
10
Early Intervention, Educational
10
Zoledronic Acid
9
Interviews as Topic
9
olaparib
8
Standard of Care
8
Psychiatric Rehabilitation
8
Therapeutics
7
Magnetic Resonance Spectroscopy
7
Gemcitabine
7
Fulvestrant
7
durvalumab
6
Paclitaxel
6
Nivolumab
6
Methods
6
Educational Status
6
Carboplatin
6
enzalutamide
5
Trastuzumab
5
Radiosurgery
5
Exercise
5
Cyclophosphamide
5
palbociclib
4
Taxes
4
Sirolimus
4
Letrozole
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Platinum
×
Breast
×
Clear all
NCT06769425
2025-06-24
HS-10502
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
Recruiting
157 enrolled